Eligible AACR 2019 Annual Meeting Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 8 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 presentations: 1 to 25 of 195
Introduction
Chairperson: Herbert M. Pinedo, M.D., Ph.D.
VUMC Cancer Center, Amsterdam, The Netherlands
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
Transfer of drug resistance genes into bone marrow stem cells
Joseph R. Bertino, M.D.
The Cancer Institute of New Jersey, New Brunswick, NJ
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
Resistance to anti-VEGF therapy
Lee M. Ellis, M.D.
UT M.D. Anderson Cancer Center, Houston, TX
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
Resistance to kinase inhibitors in CML
Neil P. Shah, M.D., Ph.D.
UCSF School of Medicine, San Francisco, CA
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
DNA repair enzymes and platinum resistance
Lloyd R. Kelland, D.Sc., Ph.D.
University College, London, United Kingdom
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
Introduction
Chairperson: Arie Zask, Ph.D.
Wyeth Research, Pearl River, NJ
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
Targeting apoptosis via chemical design
Maurizio Pellecchia, Ph.D.
The Burnhman Institute, La Jolla, CA
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
Introduction
Chairperson: Eric H. Rubin, M.D.
The Cancer Institute of New Jersey, New Brunswick, NJ
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
Rational (and irrational) incorporation of biomarkers into early clinical trials
Mark J. Ratain, M.D.
University of Chicago, Chicago, IL
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
Go/no-go decisions: Postcards from the edge
Peter T. C. Ho, M.D., Ph.D.
GlaxoSmithKline, Collegeville, PA
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
Introduction
Chairperson: Leslie Bernstein, Ph.D.
City of Hope, Duarte, CA
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
Diet and nutrients
Maria Elena Martinez, Ph.D.
Arizona Cancer Center, Tucson, AZ
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
Obesity
Dr. Katherine Henderson
City of Hope, Duarte, CA
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
Physical activity
Leslie Bernstein, Ph.D.
City of Hope, Duarte, CA
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
Hormones and other drugs
Graham A. Colditz, Dr., P.H., M.B.B.S.
Washington University School of Medicine, St. Louis, MO
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
Introduction
Chairperson: Phillip A. Dennis, M.D., Ph.D.
National Cancer Institute, Bethesda, MD
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
An overview of Akt
Phillip A. Dennis, M.D., Ph.D.
National Cancer Institute, Bethesda, MD
from 2008 Annual Meeting on April 12, 2008 8:00 AM-10:00 AM
Introduction
Chairperson: Matthew V. Lorenzi, Ph.D.
Bristol-Myers Squibb, Princeton, NJ
from 2008 Annual Meeting on April 12, 2008 10:15 AM-12:15 PM
Integrative approaches to identify and validate kinase oncogenes
William C. Hahn, M.D., Ph.D.
Dana-Farber Cancer Institute, Boston, MA
from 2008 Annual Meeting on April 12, 2008 10:15 AM-12:15 PM
A tale of two oncogenes: Ras and FTIs versus ErbB and Iapatinib
Allen I. Oliff, M.D.
GlaxoSmithKline, Collegeville, PA
from 2008 Annual Meeting on April 12, 2008 10:15 AM-12:15 PM
A conceptual framework for multikinase inhibitors
Dr. Patrick Zarrinkar
Ambit Biosciences, San Diego, CA
from 2008 Annual Meeting on April 12, 2008 10:15 AM-12:15 PM
Introduction
Chairperson: George F. Vande Woude, Ph.D.
Van Andel Research Institute, Grand Rapids, MI
from 2008 Annual Meeting on April 12, 2008 10:15 AM-12:15 PM
Met as a therapeutic target in upper aerodigestive malignancies
Ravi Salgia, M.D., Ph.D.
University of Chicago Hospital, Chicago, IL
from 2008 Annual Meeting on April 12, 2008 10:15 AM-12:15 PM
Early clinical trial evaluation of Met Inhibitors
Patricia M. LoRusso, D.O.
Karmanos Cancer Institute, Wayne State University, Detroit, MI
from 2008 Annual Meeting on April 12, 2008 10:15 AM-12:15 PM
Introduction
Chairperson: Cory Abate-Shen, Ph.D.
Herbert Irving Comprehensive Cancer Center at Columbia University, New York, NY
from 2008 Annual Meeting on April 12, 2008 10:15 AM-12:15 PM
<< first | < prev page: of 8 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 presentations: 1 to 25 of 195